CT和MR新技术在肝癌TACE术后评估中的研究进展  

Research progress of Advanced techniques of CT and MRI in evaluating hepatocellular carcinoma after TACE

作　　者：悦笑斐 于群[1] 韩萍[1] YUE Xiaofei;YU Qun;HAN Ping(Department of Radiology,Wuhan Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,P.R.China)

机构地区：[1]华中科技大学同济医学院附属协和医院放射科

出　　处：《医学影像学杂志》2019年第9期1578-1581,1586,共5页Journal of Medical Imaging

基　　金：国家自然科学基金面上项目(编号:81371661)

摘　　要：肝细胞癌(HCC)是最常见的恶性肿瘤之一。TACE治疗被推荐为巴塞罗那临床分期系统(BCLC)中B期肝癌患者首选的治疗方法,合理评估TACE术后疗效有助于指导患者后续治疗,CT能谱成像和低剂量CT灌注成像是目前CT评价肝癌TACE术后疗效的新方向;弥散加权成像、灌注成像、磁共振波谱成像、普美显增强扫描、T1 mapping成像等技术成为MR评估肝癌TACE疗效的研究热点。Hepatocellular carcinoma(HCC)is one of the most common malignant tumors.Transarterial chemoembolization is recommended as the first choice of the Barcelona Clinic Liver Cancer(BCLC)for patients with HCC on stage B.Reasonable evaluation of the efficacy of TACE is of great advantages to guide the follow-up treatment of patients,Low-dose CT perfusion imaging and CT spectral imaging are new directions in evaluating the efficacy of TACE for hepatocellular carcinoma.Diffusion-weighted imaging,perfusion-weighted imaging,magnetic resonance spectroscopy,Primovist enhanced imaging and T 1 mapping imaging are focuses of evaluating the efficacy of TACE in HCC.

关 键 词：经肝动脉化疗栓塞术 肝细胞肝癌 磁共振成像 体层摄影术 X线计算机 

分 类 号：R735.7[医药卫生—肿瘤] R445.2[医药卫生—临床医学]